SCHEINBERG DAVID A 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jul 3, 2019
Insider Transaction Report
Form 4
SCHEINBERG DAVID A
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2019-07-01−10,000→ 0 totalExercise: $5.33From: 2009-07-01Exp: 2019-07-01→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2019-07-01$5.33/sh+10,000$53,300→ 56,185 total